Cardio Diagnostics Statistics
Share Statistics
Cardio Diagnostics has 477.64M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 477.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | -% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -3.77 and the forward PE ratio is null.
| PE Ratio | -3.77 |
| Forward PE | null |
| PS Ratio | 1850.92 |
| Forward PS | null |
| PB Ratio | 10.68 |
| P/FCF Ratio | -4.9 |
| PEG Ratio | n/a |
Enterprise Valuation
Cardio Diagnostics Inc. has an Enterprise Value (EV) of 31.56M.
| EV / Earnings | -3.77 |
| EV / Sales | 1849.6 |
| EV / EBITDA | -20.63 |
| EV / EBIT | -4.36 |
| EV / FCF | -4.9 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.29 |
| Quick Ratio | 3.29 |
| Debt / Equity | 0.13 |
| Total Debt / Capitalization | 11.22 |
| Cash Flow / Debt | -15.17 |
| Interest Coverage | -1.08 |
Financial Efficiency
Return on equity (ROE) is -2.83% and return on capital (ROIC) is -171.66%.
| Return on Equity (ROE) | -2.83% |
| Return on Assets (ROA) | -1.88% |
| Return on Capital (ROIC) | -171.66% |
| Revenue Per Employee | 2.44K |
| Profits Per Employee | -1.20M |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 4.68, so Cardio Diagnostics 's price volatility has been higher than the market average.
| Beta | 4.68 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 75.21 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Cardio Diagnostics had revenue of $17.07K and earned -$8.38M in profits. Earnings per share was $-0.66.
| Revenue | 17.07K |
| Gross Profit | 17.07K |
| Operating Income | -7.24M |
| Net Income | -8.38M |
| EBITDA | -1.53M |
| EBIT | -7.24M |
| Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has $1.28M in cash and $1.26M in debt, giving a net cash position of $22.50K.
| Cash & Cash Equivalents | 1.28M |
| Total Debt | 1.26M |
| Net Cash | 22.50K |
| Retained Earnings | -14.37M |
| Total Assets | 4.48M |
| Working Capital | 2.32M |
Cash Flow
In the last 12 months, operating cash flow was -$5.67M and capital expenditures -$772.94K, giving a free cash flow of -$6.45M.
| Operating Cash Flow | -5.67M |
| Capital Expenditures | -772.94K |
| Free Cash Flow | -6.45M |
| FCF Per Share | -0.51 |
Margins
Gross margin is 100%, with operating and profit margins of -42.44K% and -49.09K%.
| Gross Margin | 100% |
| Operating Margin | -42.44K% |
| Pretax Margin | -49.09K% |
| Profit Margin | -49.09K% |
| EBITDA Margin | -8.97K% |
| EBIT Margin | -42.44K% |
| FCF Margin | -37.77K% |
Dividends & Yields
CDIOW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for CDIOW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 31.72 |
| Piotroski F-Score | 4 |